A study of over 80,000 patients confirmed another strong reason to prevent young people from repetitive head blows.
Most neurologists reach for levetiracetam monotherapy for children with early onset, nonsyndromic epilepsy initially. This study questions that practice.
Marijuana has been employed since ancient times for the treatment of epilepsy. However, rigorous scientific data supporting its efficacy has been essentially nonexistent until recently.
Researchers evaluated gender differences in hospitalization for stroke among patients with atrial fibrillation. Key results and take-home points here.
Delirium, psychosis, impulse control disorders: these are among the psychiatric problems associated with dopaminergic medications that control PD motor symptoms. Take the quiz.
What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?
Exposure to airborne particulate matter from fires in California to plague in Madagascar: here are quiz questions about medical matters that have made world headlines.
Virtual housecalls to patients with Parkinson's disease are not only feasible and efficient, but patients appear to like them. Details from a national study tell the story here.
In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.
Do you consider sleep deprivation to be a possible contributor to your patients’ symptoms? Do you routinely ask your patients about sleep deprivation?
A new study makes the case for alternatives to opioids in the treatment of migraine.
Which vitamins and supplements have shown promise in treating dementia and preventing cognitive decline?
A number of agents are being investigated as potential new therapies for narcolepsy. Here's a brief overview.
For a variety of reasons, the prevalence of stroke is higher in women than it is in men. Globally, the highest burden of stroke lies with women in low- and middle-income countries.
Do you want to make your voice heard? Then join the Neurology Times Advisory Board!